Cyber Incident Victim: Cencora
Date:
Feb 2024
Location:
United States of America
Summary
Cencora disclosed a cybersecurity incident involving unauthorized access to its information systems, resulting in a data breach. The company confirmed the attack compromised certain data, though specific details regarding the scope of impacted information or operational disruptions were not publicly elaborated. The disclosure followed standard breach notification procedures without indicating attribution to known threat actors or ransomware groups.
| CIA Posture | Motives | Tactics, Techniques & Procedures |
|---|---|---|
| Available to members | 1 motive | 1 technique |
| Threat Actors | Type | Location |
|---|---|---|
| 0 actors | Available to members | Available to members |
Description
Cencora, a healthcare and pharmaceuticals company, publicly disclosed a cybersecurity incident involving unauthorized access to its information systems on February 21, 2024. The breach resulted in a compromise of company data, though specific details regarding the type or volume of data exfiltrated were not provided in the disclosure. The attack disrupted normal business operations, impacting the integrity and availability of Cencora’s internal systems. The company did not specify the duration of the breach, the initial attack vector, or the exact timeline from intrusion detection to containment. No information was released regarding whether ransomware or extortion tactics were employed by the threat actors. Cencora’s disclosure did not identify suspected threat actors or attribute the attack to any known cybercriminal group or nation-state. The company confirmed the incident was reported to regulatory authorities, though no further details about law enforcement involvement or breach notification timelines were provided.
The incident’s operational impact extended to Cencora’s core business functions, though the company did not quantify financial losses, service interruptions, or recovery costs. No customer-facing systems or third-party supply chain disruptions were explicitly mentioned in the available reporting. Cencora initiated an internal investigation with external cybersecurity experts to assess the breach’s scope and implement remediation measures. The disclosure did not outline specific containment actions, system restoration processes, or enhanced security controls deployed post-incident. No evidence suggested patient safety risks or clinical care disruptions stemming from the attack. The breach occurred amid unrelated cyberattacks against other healthcare entities, including a confirmed BlackCat ransomware operation targeting UnitedHealth Group’s Change Healthcare unit, though no connection between these incidents was indicated. Cencora’s public statement remained limited to initial breach confirmation without subsequent updates on investigation findings or long-term mitigation strategies.